Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FA939
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,234
Award facts
- Contract value 100% obligated
- $11,234.33 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,234.33 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 1, 2025, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Pharmaceutical Prime Vendor Global Program IDC with DLA Troop Support Medical (SPE2DX), a $999.99 billion indefinite delivery contract running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement. The company supplies an extensive portfolio of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through its federal contracts with DLA, the company supports military healthcare programs and other government customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to deliver diverse medical products through competitive procurement at varying order values positions it as a primary supplier within DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FA939?
SPE2DU26FA939 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DU26FA939 worth?
The government has obligated $11,234 on SPE2DU26FA939.
Is contract SPE2DU26FA939 an order under another contract?
Yes. SPE2DU26FA939 is a delivery order under SPE2DU25D4210, an indefinite delivery contract.
Was contract SPE2DU26FA939 competed?
The extent of competition for SPE2DU26FA939 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award